Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 May 29:15:837-843.
doi: 10.2147/IJWH.S403347. eCollection 2023.

Diagnostic Performance of Anti-Müllerian Hormone, Luteinizing Hormone to Follicle-Stimulating Hormone Ratio, Testosterone, and Prolactin to Predict Polycystic Ovary Syndrome Among Sudanese Women

Samia Alhassan  1 , Abdelgadir Elmugadam  1 , Ghada A Elfadil  1 , Nuha Abubaker  1 , Elyasa M Elfaki  2 , Alneil Hamza  2 , Ezeldine K Abdalhabib  2 , Tarig Karar  3   4
Affiliations

Diagnostic Performance of Anti-Müllerian Hormone, Luteinizing Hormone to Follicle-Stimulating Hormone Ratio, Testosterone, and Prolactin to Predict Polycystic Ovary Syndrome Among Sudanese Women

Samia Alhassan et al. Int J Womens Health. .

Abstract

Background: Polycystic ovary syndrome (PCOS) is one of the most important contributing factors to infertility. The diagnosis of PCOS is not an easy procedure, as the signs and symptoms are heterogeneous and of undefined etiology. There are only a few published studies that address the diagnostic performance of anti-Müllerian hormone in diagnosis of PCOS in sub-Saharan Africa including Sudan.

Objective: This study aims to assess anti-Müllerian hormone (AMH), luteinizing to follicle-stimulating hormone ratio (LH: FSH), total testosterone (TT), and prolactin (PRL) levels among PCOS. In addition, we determine if AMH can be used as a predictor of PCOS among Sudanese women.

Methods: There were 600 women enrolled in this observational cross-sectional study, 300 of whom had PCOS, and 300 of whom healthy women; PCOS was diagnosed using the Rotterdam criteria. On days 2-4 of the menstrual cycle, serum LH, FSH, AMH, TT, and PRL levels were measured for all participants. Diagnostic performance of these parameters for PCOS was determined by receiver operating characteristic (ROC) curve.

Results: Significantly higher means among PCOS regarding their BMI, AMH; LH: FSH ratio; TT; PRL, whereas significantly inverse in FSH compared with normal ovulatory women. On ROC analysis, AMH had the largest operating characteristic curve at cut-off >3.95 ng/mL; AUC = 0.999 with Youden's index 0.99%, followed by LH: FSH ratio at cut-off 0.749; AUC=0.932; Youden's index 0.813%, TT cut-off 0.82 mIU/L, AUC=0.852 with Youden's index 0.58, while PRL showed the lowest AUC=0.627 with cut-off 15.3 ng/mL, Youden's index was 0.18%, P. value<0.001.

Conclusions: Sudanese women with PCOS had higher serum AMH level, LH:FSH ratio, and TT level. Moreover, AMH level has better discriminative power and good diagnostic potency for the diagnosis of PCOS among Sudanese.

Keywords: AMH; LH:FSH ratio; PCOS women; PRL; Sudan; TT.

PubMed Disclaimer

Conflict of interest statement

The authors report that there are no conflicts of interest in this work.

Figures

Figure 1
Figure 1
Receiver operating characteristic curve for discriminating between different hormones markers in diagnosing polycystic ovarian syndrome. *p value <0.05 is considered significant.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Escobar-Morreale HF. Polycystic ovary syndrome: definition, a etiology, diagnosis and treatment. Nat Rev Endocrinol. 2018;14(5):270. doi:10.1038/nrendo.2018.24 - DOI - PubMed
    1. Franks S. Polycystic ovary syndrome. N Engl J Med. 1995;333(13):853–861. doi:10.1056/NEJM199509283331307 - DOI - PubMed
    1. El Hayek S, Bitar L, Hamdar LH, Mirza FG, Daoud G. Poly cystic ovarian syndrome: an updated overview. Front Physiol. 2016;7:124. doi:10.3389/fphys.2016.00124 - DOI - PMC - PubMed
    1. Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol. 2011;7(4):219–231. doi:10.1038/nrendo.2010.217 - DOI - PubMed
    1. Teede H, Misso M, Costello M, et al. International evidence-based guideline for the assessment and management of polycystic ovary syndrome. National Health and Medical Research Council (NHMRC); 2018:1–198.